DK0931265T3 - Diagnistisk metode for aterosklerose - Google Patents

Diagnistisk metode for aterosklerose

Info

Publication number: DK0931265T3
Authority: DK; Denmark
Prior art keywords: atherosclerosis; diagnostic method; level; hydroxyphenylacetaldehyde; lysine
Prior art date: 1996-09-09

Application number

DK97939604T

Other languages

English (en)

Inventor

Jay W Heinecke

Original Assignee

Univ Washington

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-09

Filing date

1997-09-03

Publication date

2002-07-29

1997-09-03 Application filed by Univ Washington filed Critical Univ Washington

2002-07-29 Application granted granted Critical

2002-07-29 Publication of DK0931265T3 publication Critical patent/DK0931265T3/da

Links

201000001320 Atherosclerosis Diseases 0.000 title abstract 2
238000002405 diagnostic procedure Methods 0.000 title abstract 2
XZVNINGTWINTKV-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;2-(4-hydroxyphenyl)acetaldehyde Chemical compound NCCCC[C@H](N)C(O)=O.OC1=CC=C(CC=O)C=C1 XZVNINGTWINTKV-ZSCHJXSPSA-N 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
210000001539 phagocyte Anatomy 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Microbiology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Hydrogenated Pyridines (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK97939604T 1996-09-09 1997-09-03 Diagnistisk metode for aterosklerose DK0931265T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/709,700 US5731208A (en)	1996-09-09	1996-09-09	Method of detecting conditions indicative of atherosclerosis
PCT/US1997/015115 WO1998010295A1 (en)	1996-09-09	1997-09-03	Diagnostic method for atherosclerosis

Publications (1)

Publication Number	Publication Date
DK0931265T3 true DK0931265T3 (da)	2002-07-29

Family

ID=24850989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97939604T DK0931265T3 (da)	1996-09-09	1997-09-03	Diagnistisk metode for aterosklerose

Country Status (11)

Country	Link
US (1)	US5731208A (da)
EP (1)	EP0931265B1 (da)
JP (1)	JP3553612B2 (da)
AT (1)	ATE217089T1 (da)
AU (1)	AU4165297A (da)
CA (1)	CA2264754C (da)
DE (1)	DE69712352T2 (da)
DK (1)	DK0931265T3 (da)
ES (1)	ES2176778T3 (da)
PT (1)	PT931265E (da)
WO (1)	WO1998010295A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6727102B1 (en)	1997-06-20	2004-04-27	Leuven Research & Development Vzw	Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6133039A (en) *	1998-02-09	2000-10-17	Washinton University	In vivo method for determination of oxidative stress
US6096556A (en) *	1998-02-09	2000-08-01	Washington University	Method for the determination of oxidative stress
SE9802402D0 (sv) *	1998-07-03	1998-07-03	Karolinska Innovations Ab	Method of diagnosing cardiovascular disease and early atherosclerosis
US6309888B1 (en) *	1998-09-04	2001-10-30	Leuven Research & Development Vzw	Detection and determination of the stages of coronary artery disease
DE60031357T2 (de) *	1999-12-29	2007-08-30	PerkinElmer Life Sciences, Inc., Norton	Geräte, Kits und Verfahren zum Testen von Körperflüssigkeiten zum Screening vonNeugeborenen durch Tandem-Massenspektrometrie-Kits
US7780950B2 (en) *	2002-01-02	2010-08-24	The Cleveland Clinic Foundation	Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
CA2440978C (en) *	2001-01-02	2013-04-02	The Cleveland Clinic Foundation	Myeloperoxidase, a risk indicator for cardiovascular disease
US6939716B2 (en) *	2001-09-19	2005-09-06	Washington University	Method for detecting conditions indicative of sepsis
US7459286B1 (en)	2003-10-22	2008-12-02	The Cleveland Clinic Foundation	Assessing the risk of a major adverse cardiac event in patients with chest pain
JP4625812B2 (ja)	2003-12-05	2011-02-02	ザクリーブランドクリニックファウンデーション	心臓血管疾患に対するリスクマーカー
US20050181451A1 (en) *	2004-02-12	2005-08-18	Bates Harold M.	Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
WO2006020498A2 (en) *	2004-08-11	2006-02-23	The Cleveland Clinic Foundation	Therapeutic agents and methods for cardiovascular disease
US9744155B2 (en)	2012-03-28	2017-08-29	Ixcela, Inc.	IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
CA2938454A1 (en) *	2014-01-31	2015-08-06	Ixcela, Inc.	Covalently bound metabolites as biomarkers
US11041847B1 (en)	2019-01-25	2021-06-22	Ixcela, Inc.	Detection and modification of gut microbial population

1996
- 1996-09-09 US US08/709,700 patent/US5731208A/en not_active Expired - Fee Related
1997
- 1997-09-03 PT PT97939604T patent/PT931265E/pt unknown
- 1997-09-03 DE DE69712352T patent/DE69712352T2/de not_active Expired - Fee Related
- 1997-09-03 CA CA002264754A patent/CA2264754C/en not_active Expired - Fee Related
- 1997-09-03 JP JP51273998A patent/JP3553612B2/ja not_active Expired - Fee Related
- 1997-09-03 AU AU41652/97A patent/AU4165297A/en not_active Abandoned
- 1997-09-03 EP EP97939604A patent/EP0931265B1/en not_active Expired - Lifetime
- 1997-09-03 ES ES97939604T patent/ES2176778T3/es not_active Expired - Lifetime
- 1997-09-03 AT AT97939604T patent/ATE217089T1/de not_active IP Right Cessation
- 1997-09-03 WO PCT/US1997/015115 patent/WO1998010295A1/en not_active Ceased
- 1997-09-03 DK DK97939604T patent/DK0931265T3/da active

Also Published As

Publication number	Publication date
DE69712352T2 (de)	2002-11-14
WO1998010295A1 (en)	1998-03-12
US5731208A (en)	1998-03-24
EP0931265A1 (en)	1999-07-28
ATE217089T1 (de)	2002-05-15
DE69712352D1 (de)	2002-06-06
JP2001502792A (ja)	2001-02-27
PT931265E (pt)	2002-09-30
ES2176778T3 (es)	2002-12-01
EP0931265B1 (en)	2002-05-02
JP3553612B2 (ja)	2004-08-11
AU4165297A (en)	1998-03-26
CA2264754C (en)	2005-11-22
CA2264754A1 (en)	1998-03-12

Similar Documents

Publication	Publication Date	Title
PT931264E (pt)	2002-08-30	Metodo de diagnostico da aterosclerose
DK0931265T3 (da)	2002-07-29	Diagnistisk metode for aterosklerose
DE69631738D1 (de)	2004-04-15	Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
NO971348D0 (no)	1997-03-21	Pröveenhet for oppsamling og undersökelse av kroppsvæske
AU1726797A (en)	1997-08-28	A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
DE69635174D1 (de)	2005-10-13	Nichtinvasive Vorrichtung zur Blutuntersuchung
DE69736527D1 (de)	2006-09-28	Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung
AU8160598A (en)	1999-01-04	Diagnostic complex for measurement of the condition of biological tissues and liquids
DE69623628D1 (de)	2002-10-17	Virtuelles medizinisches instrument zum medizinischen diagnostiktesten von patienten
FI952131A7 (fi)	1995-11-06	Analyysijärjestelmä potilaan verestä analysoitavan aineen tarkkailemiseksi
DE69531743D1 (de)	2003-10-16	System und verfahren zur diagnose von krankheiten an lebendem gewebe
AU1364292A (en)	1993-09-13	Non-invasive device and method for determining concentrations of various components of blood or tissue
DE69732223D1 (de)	2005-02-17	Ultraschall-Echographiesystem zur Untersuchung von Arterien
DE69601544D1 (de)	1999-03-25	Harnsammel und Untersuchungsvorrichtung, und Gebrauchsverfahren
ATE263505T1 (de)	2004-04-15	Mittels vakuum verbesserter transdermaler flüssigkeitstransport
FI963893A7 (fi)	1996-09-27	Kertakäyttölaite kehollisen nesteen kokoamista ja mahdollista analysointia varten
EP0924523A3 (de)	2002-03-06	Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
EA199900138A1 (ru)	1999-06-24	Обнаружение активности гепараназы млекопитающих и очистка гепараназы млекопитающих
HU9202178D0 (en)	1992-10-28	Method for detecting irregularities of bone and other connective tissues in human beings and in animals
ATE529743T1 (de)	2011-11-15	Verfahren und kits zur tumorigenizitätsdiagnose
SE9401883L (sv)	1995-12-02	Sätt vid diagnosticering av födoämnesintolerans/allergi samt instrument för diagnostiseringen
EP0886142A4 (en)	2000-07-26	METHOD FOR DETERMINING ANTI-GADII ANTIBODIES AND METHOD FOR DIAGNOSING CANCER
ZA98665B (en)	1998-08-19	Method and apparatus for the measurement of blood coagulation properties with absorbent materials
DE68911574D1 (de)	1994-02-03	Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
ATE220458T1 (de)	2002-07-15	Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten